FAQ
open menu
About Us
About Us
Management Team
Our Companies
Nebula Genomics
ProPhase Diagnostics
ProPhase Biopharma
Pharmaloz Manufacturing
TK Supplements
Investor Relations
Presentations
News & Events
Press Releases
Media Mentions
IR Calendar
Email Alerts
Company Info
Management Team
Contacts
FAQ
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Contact Us
Corporate
Diagnostics
Pharmaloz
TKSupplements
All SEC Filings
Investors
Investors
Overview
Presentations
News & Events
Press Releases
Media Mentions
IR Calendar
Email Alerts
Company Info
Management Team
Contacts
FAQ
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
15-12G
3
3/A
4
4/A
424B3
424B5
8-A12G
8-A12G/A
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFC14A
DFAN14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PREC14A
PREN14A
PRER14A
PRRN14A
S-3
S-3/A
S-3MEF
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
Date
Form
Description
PDF
XBRL
Pages
05/11/15
DEF 14A
Definitive proxy statements
84
04/30/15
10-K/A
Annual report pursuant to Section 13 and 15(d)
Documents
expand_more
EX-3.1
EX-31.3
EX-31.4
34
04/21/15
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
78
04/17/15
8-K
Current report filing
2
03/27/15
10-K
Annual report pursuant to Section 13 and 15(d)
Documents
expand_more
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
65
03/26/15
8-K
Current report filing
Documents
expand_more
EX-99.1
7
03/09/15
SC 13D
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
Documents
expand_more
EX-1
11
02/05/15
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
01/15/15
8-K
Current report filing
Documents
expand_more
EX-99.1
EX-99.2
32
01/14/15
8-K
Current report filing
2
rss_feed
Filing RSS
arrow_back
1…
34
35
36
37
38
39
40
41
42
43
…84
arrow_forward
Email Alerts
Contacts
RSS News Feed